Advanced Neural Multi-Electrode Array (MEA) Electrophysiology Services
At Creative Biolabs, we understand the critical need for precise, high-throughput, and physiologically relevant measurement of neuronal activity in both basic neuroscience research and drug development. Our Advanced Neural MEA Electrophysiology Services address the challenges faced by researchers in capturing complex neural network behaviors, assessing pharmacological effects, and modeling neurological diseases with accuracy and efficiency.
Service Highlights
Simultaneous Recording from Hundreds of Neurons
Capture complex neural network activity with high spatial and temporal resolution.
Noninvasive & Label-Free
Monitor neuronal function continuously without interfering with cell physiology or requiring dyes.
High-Throughput Screening Capabilities
Robust multi-well MEA formats support rapid compound screening and functional analysis.
Flexible Models & Configurations
Compatible with 2D neuronal cultures, 3D organoids, co-cultures, and patient-derived neurons.
Comprehensive Data Analytics
Advanced software enables detailed analysis of spikes, bursts, synchrony, and network connectivity.
Translational Research Support
Ideal for neuropharmacology, neurotoxicity, disease modeling, and neuroprosthetics development.
Unlock unparalleled insights into neuronal function with our cutting-edge MEA technology and accelerate your neuroscience research today. Contact us now to discuss your project.
What is Multi Electrode Array (MEA) Technology?
Multi Electrode Arrays are innovative platforms composed of grids of microscopic electrodes embedded in culture surfaces, designed to measure extracellular electrical signals from electrically active cells like neurons. Unlike traditional single-cell techniques, MEA captures population-level activity noninvasively and in real time, enabling researchers to observe how neurons fire and interact within complex networks.
Our in vitro MEA systems provide dynamic spatial and temporal data, revealing essential information about neuronal signaling, network formation, and functional connectivity. This technology is revolutionizing neuroscience by offering:
- Real-time monitoring of excitability and network dynamics
- High-throughput capacity for multi-well assays
- Noninvasive, label-free experimental workflows
- Compatibility with a wide range of neural cell models
MEA technology offers a powerful and flexible platform tailored to your specific research needs. Discover how our MEA solutions can elevate your project—Request a consultation today.
Figure 1. MEA recordings of the human brain and corresponding hPSC-derived models.1,6
Neural Electrophysiology Using MEA
MEA technology offers a revolutionary approach to studying the functional electrophysiology of neurons by providing simultaneous, high-resolution recording from large populations of electrically active cells. When neurons are cultured on MEA plates, they establish synaptic connections, forming complex and dynamic networks that closely mimic in vivo neural circuits.
Platform capabilities with MEA
Our MEA platform is designed to capture the extracellular electrical signals generated by these networks with microsecond temporal precision and micrometer spatial resolution. Each electrode detects changes in local field potentials and individual neuronal spikes as neurons communicate through action potentials. This enables the detailed characterization of:
Neuronal firing patterns Including spontaneous activity and responses to stimuli, essential for understanding excitability and functional states.
Network bursts and oscillations Coordinated activity across populations that reflects synaptic connectivity and network synchronization.
Synaptic plasticity and modulation Measurement of changes over time in response to pharmacological agents or environmental shifts, crucial for learning and memory studies.
Neural network connectivity Mapping functional connectivity within and between cultured neural populations via spike-timing and cross-correlation analyses.
MEA-based stimulation capabilities
In addition to recording, MEA systems can deliver controlled electrical stimuli to specific electrodes, enabling interrogation of neural circuit dynamics and plasticity mechanisms. This precise stimulation capability supports studies on neuronal excitability, network entrainment, and sensory-motor integration.
Our service supports a wide variety of neuronal models, including primary neurons, stem cell-derived neurons, 3D organoids, and co-cultures, providing flexible platforms that replicate diverse physiological and pathological states. Long-term recordings allow assessment of network development and maturation phases, providing insights into dynamic changes in connectivity and function.
Through advanced signal processing and machine learning algorithms, we extract detailed electrophysiological biomarkers from raw data, such as spike sorting, burst detection, and network synchrony metrics. These rich datasets enhance your ability to decode complex neuronal behaviors, model neurological diseases, and evaluate candidate therapeutics.
Partner with us to leverage MEA-based neural electrophysiology for a comprehensive, scalable, and physiologically relevant investigation of neuronal networks, accelerating the translational impact of your neuroscience and neuropharmacology research.
Service Workflow
Our comprehensive workflow is designed to maximize data quality, reproducibility, and relevance at every stage of your MEA project:
-
Project Consultation & Study Design
- Define electrophysiological endpoints aligned with MEA capabilities: spontaneous firing rate, spike waveform characteristics, burst morphology, network synchrony, and functional connectivity metrics.
- Select neuronal models and culture formats optimized for MEA readouts (2D microplates, high-density electrodes, or 3D MEA integrations).
- Establish sampling cadence, recording duration, and stimulation schematics to address hypotheses on excitability, plasticity, and network dynamics.
- Predefine data governance, preprocessing pipelines, and benchmarking criteria using ground-truth references and pilot runs.
-
Sample Preparation & Cell Culture
- Source recommendations: primary neurons, iPSC-derived neurons, or organoids with validated MEA compatibility; provide quality control checkpoints (viability, purity, maturation stage).
- Plate preparation: surface coating (e.g., poly-D-lysine, laminin) and electrode map-aware seeding densities to ensure homogeneous contact and stable impedance.
- Recording-ready readiness checks: impedance spectroscopy to confirm electrode health, chip-to-chip variability assessment, and contamination screening.
- Documentation of culture conditions and batch metadata to support cross-batch comparability.
-
MEA Recording & Stimulation
- Recording protocol: continuous, high-sampling-rate acquisition (e.g., ≥20 kHz per channel) with real-time noise reduction and common-average referencing to enhance signal-to-noise.
- Environmental control: maintain physiological temperature, CO2, and humidity; monitor drift and compensate for electrode impedance changes over time.
- Stimulation strategies: closed-loop or open-loop electrical stimulation targeting specific electrode subsets to probe causality in network dynamics; include stimulation paradigms for plasticity induction (e.g., tetanic, paired-pulse, or train protocols).
- Data integrity: implement automated artifact rejection, line-noise suppression, and synchronization with external stimuli for precise spike-timing analyses.
-
Data Processing & Advanced Analysis
- Spike detection and sorting: rule-based and ML-powered spike sorting tailored to MEA signals; quantify spike-sorting confidence and reproducibility.
- Burst and network metrics: define bursts by amplitude/ISI criteria; compute network bursts, synchrony indices, and cross-correlation connectivity maps.
- Connectivity modeling: infer functional graphs using time-lagged correlations, Granger causality, or transfer entropy; assess network maturation trajectories.
- Pharmacology and perturbation analysis: model dose-response relationships, temporal dynamics of excitability, and plasticity indices under compound exposure or environmental changes.
- Quality metrics: provide data quality scores, electrode hit rates, and reproducibility diagnostics across wells and plates.
-
Comprehensive Reporting & Interpretation
- Visualizations: high-resolution raster plots, spike trains, heatmaps of connectivity, and longitudinal maturation curves with confidence intervals.
- Interpretive summaries: tie electrophysiological biomarkers to experimental hypotheses, with caveats on model limitations and batch effects.
- Reproducibility packets: raw data access, preprocessing scripts, and standardized analysis notebooks for downstream research or regulatory review.
- Executive deliverables: concise executive summaries plus technical appendices tailored to the audience.
-
Ongoing Support & Collaboration
- Iterative reanalysis: reprocess data with updated pipelines or hypotheses; compare across pilot and full-scale studies.
- Protocol optimization: refine stimulation parameters, recording schedules, and culture conditions based on interim findings.
- Training & handover: provide model-specific training for in-house teams and comprehensive documentation for long-term sustainability.
Our structured workflow ensures that every aspect of your MEA study is expertly managed from start to finish, delivering actionable insights efficiently. Discuss your project with our team today.
Applications of MEA Technology in Neuroscience
MEA technology is a versatile and powerful tool at the forefront of neuroscience research and drug development. Recent technological advances have expanded its application scope and analytical depth, enabling breakthroughs across multiple domains:
MEA technology sits at the nexus of neuroscience research and drug development, translating complex neural dynamics into actionable insights. Recent advances fuse MEA platforms with state-of-the-art research tools to reveal deeper layers of brain function and dysfunction. In neuropharmacology, high-density MEA systems are paired with advanced analytics and machine learning to decode how novel compounds reshape network-level activity, uncovering subtle shifts in excitability, synchrony, and circuit motifs that signal mechanism of action and therapeutic potential. In safety pharmacology, MEA readouts from human iPSC-derived neural networks capture acute and chronic neurotoxic effects with unprecedented physiological relevance, enabling earlier risk stratification and more predictive safety profiles.
Figure 2. MEA platform overview for integrating brain dynamics across scales.2,6
Disease modeling benefits from patient-specific, gene-edited, and isogenic iPSC-derived networks integrated with MEA and organoid technologies. This combination illuminates developmental trajectories, maturation milestones, and disease-specific network signatures in neurodevelopmental and neurodegenerative disorders, offering rich phenotypes for biomarker discovery and target validation. Longitudinal recordings in 3D cultures and organoids reveal how connectivity and oscillatory dynamics evolve over weeks to months, while targeted stimulation paradigms paired with real-time MEA feedback illuminate the cellular and circuit mechanisms underlying learning, plasticity, and memory.
Figure 3. Flowchart of potential applications of iPSC systems.3,6
Multimodal integration further enhances interpretability. By coupling MEA with calcium imaging, optogenetics, and multi-omics, researchers can trace how molecular states translate into network behavior, identify hub nodes, and map compensatory pathways that sustain function in disease contexts. This multimodal view supports translational pipelines that connect in vitro network phenotypes to in vivo biomarkers, shortening the path from discovery to therapeutic strategy.
Figure 4. Calcium imaging and MEA recording are 2 mainstream strategies for neural network detection in brain organoids.5,6
In the era of precision medicine, standardized MEA readouts on patient-derived models enable genotype-to-phenotype correlations and differential drug responsiveness, underpinning regulatory-aligned safety and efficacy assays. The result is a more informative, faster, and more translatable research paradigm that aligns scientific discovery with practical, client-facing outcomes.
Figure 5. Novel approach to involve precision medicine.4,6
Harness the full potential of state-of-the-art MEA technology with our expert-driven services tailored to your neuroscience research needs. Request a consultation to explore how MEA can enhance your projects.
Trusted Partner for Neuroscience Research
We pride ourselves on being a reliable and innovative partner trusted by leading academic institutions, pharmaceutical companies, and biotechnology firms worldwide. Our commitment to rigorous quality standards, scientific excellence, and transparent communication ensures that your projects are supported from experimental design to data interpretation.
-Model-Service-Solutions-for-CNS-Drug-Discovery-10.svg)
-Model-Service-Solutions-for-CNS-Drug-Discovery-11.svg)
-Model-Service-Solutions-for-CNS-Drug-Discovery-12.svg)
-Model-Service-Solutions-for-CNS-Drug-Discovery-13.svg)
-Model-Service-Solutions-for-CNS-Drug-Discovery-14.svg)
-model-service-solutions-for-cns-drug-discovery-15.webp)
Join the many researchers who have accelerated their discoveries through our trusted MEA services. Contact us today to learn how we can support your neuroscience goals.
Frequently Asked Questions
References
- Pelkonen, Anssi, et al. “Functional Characterization of Human Pluripotent Stem Cell-Derived Models of the Brain with Microelectrode Arrays.” Cells, vol. 11, no. 1, Dec. 2021, p. 106. DOI.org, https://doi.org/10.3390/cells11010106.
- Emery, Brett Addison, et al. “MEA‐seqX: High‐Resolution Profiling of Large‐Scale Electrophysiological and Transcriptional Network Dynamics.” Advanced Science, vol. 12, no. 20, May 2025, p. 2412373. DOI.org, https://doi.org/10.1002/advs.202412373.
- Tanaka, Atsushi, et al. “Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.” International Journal of Molecular Sciences, vol. 16, no. 8, Aug. 2015, pp. 18894–922. DOI.org, https://doi.org/10.3390/ijms160818894.
- Fujita, Kenji, et al. “Polypharmacy and Precision Medicine.” Cambridge Prisms: Precision Medicine, vol. 1, 2023, p. e22. DOI.org, https://doi.org/10.1017/pcm.2023.10.
- Gu, Longjun, et al. “Functional Neural Networks in Human Brain Organoids.” BME Frontiers, vol. 5, Jan. 2024, p. 0065. DOI.org, https://doi.org/10.34133/bmef.0065.
- Distributed under Open Access license CC BY 4.0, without modification.
Request a Quote
Fill out the form below, and our expert team will contact you to design your custom project and accelerate breakthrough innovations.